n-Butyl lactate

[ Density]:
1.0±0.1 g/cm3

[ Boiling Point ]:
189.4±8.0 °C at 760 mmHg

[ Melting Point ]:
−28 °C(lit.)

[ Molecular Formula ]:
C₇H₁₄O₃

[ Molecular Weight ]:
146.184

[ Flash Point ]:
69.4±0.0 °C

[ Exact Mass ]:
146.094299

[ PSA ]:
46.53000

[ LogP ]:
0.88

[ Vapour density ]:
5.04 (vs air)

[ Vapour Pressure ]:
0.2±0.8 mmHg at 25°C

[ Index of Refraction ]:
1.432

[ Water Solubility ]:
42 g/L (25 ºC)

Click to get detail MSDS

CHEMICAL IDENTIFICATION

RTECS NUMBER :: OD4025000

CHEMICAL NAME :: Lactic acid, butyl ester

CAS REGISTRY NUMBER :: 138-22-7

BEILSTEIN REFERENCE NO. :: 1721597

LAST UPDATED :: 199712

DATA ITEMS CITED :: 21

MOLECULAR FORMULA :: C7-H14-O3

MOLECULAR WEIGHT :: 146.21

WISWESSER LINE NOTATION :: QY1&VO4

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: Standard Draize test

ROUTE OF EXPOSURE :: Administration onto the skin

SPECIES OBSERVED :: Rodent - rabbit

REFERENCE :: FCTXAV Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. Volume(issue)/page/year: 17,727,1979 ** ACUTE TOXICITY DATA **

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: >5 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: FCTXAV Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. Volume(issue)/page/year: 17,727,1979

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 12 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NPIRI* Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) Volume(issue)/page/year: 1,15,1974

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 11 gm/kg

TOXIC EFFECTS :: Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - somnolence (general depressed activity) Lungs, Thorax, or Respiration - dyspnea

REFERENCE :: FCTXAV Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. Volume(issue)/page/year: 17,727,1979

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Administration onto the skin

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: >5 gm/kg

REFERENCE :: FCTXAV Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. Volume(issue)/page/year: 17,727,1979 *** REVIEWS *** ACGIH TLV-TWA 30 mg/m3 (5 ppm) DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD-air:TWA 1 ppm (5 mg/m3) DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,33,1971 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-AUSTRALIA:TWA 5 ppm (25 mg/m3) JAN 1993 OEL-BELGIUM:TWA 5 ppm (30 mg/m3) JAN 1993 OEL-DENMARK:TWA 5 ppm (25 mg/m3) JAN 1993 OEL-FINLAND:TWA 1 ppm (6 mg/m3);STEL 3 ppm (18 mg/m3) JAN 1993 OEL-FRANCE:TWA 5 ppm (25 mg/m3) JAN 1993 OEL-THE NETHERLANDS:TWA 5 ppm (25 mg/m3) JAN 1993 OEL-SWITZERLAND:TWA 5 ppm (30 mg/m3) JAN 1993 OEL-UNITED KINGDOM:TWA 5 ppm (25 mg/m3) JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO n-BUTYL LACTATE-air:10H TWA 5 ppm REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - M1128 No. of Facilities: 242 (estimated) No. of Industries: 8 No. of Occupations: 10 No. of Employees: 3107 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - M1128 No. of Facilities: 170 (estimated) No. of Industries: 9 No. of Occupations: 15 No. of Employees: 5342 (estimated) No. of Female Employees: 1381 (estimated)

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ Hazard Codes ]:
Xi:Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26-S36-S37/39

[ WGK Germany ]:
2

[ RTECS ]:
OD4025000

[ Packaging Group ]:
I; II; III

[ HS Code ]:
2918110000

Click to get detail synthetic route

Precursor

Ammonium lactate
Butanol
2-hydroxypropionic acid
Ethyl lactate
isopropyl lactate
1,3-Dihydroxyacetone Dimer
1,3-Dihydroxyacetone
DL-Glyceric aldehyde
Methylglyoxal
D-(−)-Lactic acid

DownStream

n-Butyl lactate
(R)-O-acetyl-(n-butyl)lactate
1-(Dibromomethyl)-3-phenoxybenzene
ch3cho
Acrylic acid
butyl acrylate
Propanoic acid,2-hydroxy-, 2-butoxy-1-methyl-2-oxoethyl ester
Butyl pyruvate
Lactic acid, butylester, DL-, DL-2-(2,4,5-trichlorophenoxy)propionate (8CI)
1,2-Benzenedicarboxylicacid, 1-(2-butoxy-1-methyl-2-oxoethyl) 2-butyl ester

[ HS Code ]: 2918110000

[ Summary ]:
2918110000. lactic acid, its salts and esters. VAT:17.0%. Tax rebate rate:13.0%. Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward). MFN tariff:6.5%. General tariff:30.0%

An insight on human skin penetration of diflunisal: lipogel versus hydrogel microemulsion.

Drug Dev. Ind. Pharm. 41(1) , 141-7, (2014)

Diflunisal is a NSAID used in acute and long term management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis and symptoms of primary dysmenorrhea. However, its oral use i...

Optimization, ex vivo permeation, and stability study of lipid nanocarrier loaded gelatin capsules for treatment of intermittent claudication.

Int. J. Nanomedicine 10 , 4459-78, (2015)

In this study, an optimized nanodispersible oral dosage form (containing a lactate ester) was developed for cilostazol (CZL). CZL is a phosphodiesterase inhibitor used for intermittent claudication. W...

Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique.

Int. J. Pharm. 257(1-2) , 153-60, (2003)

A preparation method for nanoparticles based on the emulsification of a butyl lactate or benzyl alcohol solution of a solid lipid in an aqueous solution of different emulsifiers, followed by dilution ...

Suppliers

Names

Chemical & Physical Properties

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

Safety Information

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

DownStream

Customs

Articles

Related Compounds